Latest Germany News

Cyclopharm Limited reported a 17% revenue increase to a record $32.3 million in 2025, powered by a 226% surge in US Technegas sales. The company is accelerating its US rollout with plans for up to 300 installations in 2026, while advancing clinical trials beyond pulmonary embolism.

OncoSil Medical has reported record dose sales and cash receipts in the first half of FY26, supported by encouraging clinical trial results and expanded European market penetration.

PlaySide Studios reported a sharp 28% revenue decline for H1 FY26 but posted a remarkable 249% jump in profit, buoyed by cost cuts and a $7.8 million tax rebate. The company also secured a $6 million loan and inked a new global publishing deal.

EVT Limited reported a robust first half for 2026 with revenue rising 5.4% to A$683.8 million and net profit up 21.6%, driven by strong performances in Germany, Thredbo, and Hotels. Strategic acquisitions, including Pro-invest Hotels and QT Auckland, underpin the group’s growth ambitions.

Caravel Minerals has secured non-binding Letters of Interest from Finnish and German export credit agencies, marking a significant step in financing its Caravel Copper Project. This European backing complements a diversified funding strategy as the company moves towards a Final Investment Decision.

Little Green Pharma has entered a $7.8 million sale and leaseback agreement for its Western Australia production site, aiming to fuel growth in Australia and Europe while maintaining operational control.

Sonic Healthcare has reported a robust half-year performance, with revenue climbing 16.6% to A$5.45 billion and net profit rising 10.9%, underpinned by organic growth and key acquisitions. The company maintains its full-year guidance amid ongoing US business rationalisation.

Evion Group has secured formal notice from Madagascar’s Mines Ministry that its Maniry Graphite Project permits have passed technical assessment and are set for expedited approval, marking a key step towards production.

Telix Pharmaceuticals has lodged a European marketing authorization application for TLX101-Px, a novel PET imaging agent targeting glioma brain cancer, aiming to enhance diagnostic precision and patient access across major European markets.

EAU Lithium, backed by Cosmos Exploration, has formalised a negotiation framework with Bolivia’s state lithium company YLB to explore industrial-scale lithium extraction using Vulcan Energy’s innovative technology.

Smart Parking Limited has reported record first-half results for FY26, driven by strong organic growth and a successful US acquisition that boosted earnings per share by over 30%.

Pro Medicus has reported its strongest half-year performance yet, with revenue and profits surging alongside a wave of new multi-million dollar contracts and strategic AI investments. The healthcare IT leader is expanding its global footprint and cloud capabilities, setting the stage for sustained growth.